Proteomic and metabolic characterization of a Candida albicans mutant resistant to the antimicrobial peptide MUC7 12-mer

Department of Oral Biology, University at Buffalo, the State University of New York, Buffalo, NY 14214, USA.
FEMS Immunology & Medical Microbiology (Impact Factor: 2.55). 09/2008; 54(1):80-91. DOI: 10.1111/j.1574-695X.2008.00450.x
Source: PubMed

ABSTRACT MUC7 12-mer is a cationic peptide derived from the N-terminal portion of human mucin MUC7, exhibiting potent antibacterial and antifungal properties. To advance our knowledge regarding the mechanisms of action of MUC7 peptide against an opportunistic fungal pathogen Candida albicans, we sought to develop and characterize mutant(s) resistant to this peptide. One of the selected mutants, designated #37, was much less susceptible to the MUC7 12-mer in a killing assay than the parental strain (ED(50)>40 vs. c. 6 microM, respectively). Difference gel electrophoresis (DIGE) analysis of the mutant revealed elevation of several glycolytic enzymes. The mutant also exhibited lowered ATP contents along with a relatively lower rate of oxygen consumption, as well as inability to grow on nonfermentable carbon sources. These properties are likely to be associated with changes in metabolic regulation, rather than lack of functional mitochondria, as determined by rhodamine 123 staining. Analysis of interaction between fluorescently labeled peptide and cells of both strains revealed that resistance of the mutant #37 is associated with changes in the process of transition between surface-bound state of the peptide to its internalization marking cell death.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Two types of mucins, MUC7 and MUC5B constitute the major salivary glycoproteins, however their metabolic turnover has not been elucidated in detail to date. This study was conducted to examine turnover of MUC7 and MUC5B in saliva, by focusing on the relationship between their deglycosylation and proteolysis. Whole saliva samples were collected from healthy individuals and incubated at 37°C in the presence of various protease inhibitors, sialidase, or a sialidase inhibitor. General degradation patterns of salivary proteins and glycoproteins were examined by SDS-polyacrylamide-gel-electrophoresis. Furthermore, changes of molecular sizes of MUC7 and MUC5B were examined by Western blot analysis. A protein band was identified as MUC7 by Western blot analysis using an antibody recognizing an N-terminal epitope. The MUC7 signal disappeared rapidly after 20-minutes of incubation. In contrast, the band of MUC7 stained for its carbohydrate components remained visible near its original position for a longer time indicating that the rapid loss of Western blot signal was due to the specific removal of the N-termimal epitope. Pretreatment of saliva with sialidase facilitated MUC7 protein degradation when compared with samples without treatment. Furthermore, addition of sialidase inhibitor to saliva prevented proteolysis of N-terminus of MUC7, suggesting that the desialylation is a prerequisite for the degradation of the N-terminal region of MUC7. The protein band corresponding to MUC5B detected in both Western blotting and glycoprotein staining showed little sign of significant degradation upon incubation in saliva up to 9 hours. MUC7 was highly susceptible to specific proteolysis in saliva, though major part of MUC5B was more resistant to degradation. The N-terminal region of MUC7, particularly sensitive to proteolytic degradation, has also been proposed to have distinct biological function such as antibacterial activities. Quick removal of this region may have biologically important implication.
    PLoS ONE 07/2013; 8(7):e69059. DOI:10.1371/journal.pone.0069059 · 3.53 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: To compare the effects of four antimicrobial peptides (MUC7 12-mer, Histatin 12-mer, cathelicidin KR20 and lactoferricin 1-11) on the yeast Saccharomyces cerevisiae, we employed a genome-wide fitness screen of combined collections of homozygous non-essential, and heterozygous essential deletion mutants. Using an arbitrary fitness score cut-off of 1 (indicating fitness defect or hypersensitivity) and -1 (indicating fitness gain or resistance), 425 strains, out of the 5902 mutants tested, exhibited altered fitness when treated with at least one peptide. Functional analysis of the 425 strains revealed enrichment among identified deletions in gene groups associated with GO terms "ribosomal subunit", "ribosome biogenesis" and "protein glycosylation", "vacuolar transport" and "Golgi vesicle transport", "negative regulation of transcription" and others. Fitness profiles of all four tested peptides were highly similar particularly among those mutant strains exhibiting the greatest fitness defects. The latter group included deletions in several genes involved in induction of the RIM101 signaling pathway, including several components of the ESCRT sorting machinery. The RIM101 signaling regulates response of yeasts to alkaline and neutral pH and high salts and our data indicate that this pathway plays also a prominent role in regulating protective measures against the all four tested peptides. In summary, the results of the chemical-genomic screens of S. cerevisiae mutant collection suggest that the four antimicrobial peptides, despite their differences in structure and physical properties, share many interactions with S. cerevisiae cells, and consequently a high degree of similarity between their modes of action.
    Antimicrobial Agents and Chemotherapy 12/2012; DOI:10.1128/AAC.01439-12 · 4.45 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Proteomic approaches have been considerably improved during the past decade and have been used to investigate the differences in protein expression profiles of cells grown under a broad spectrum of growth conditions and with different stress factors including antibiotics. In Europe, the most significant disease threat remains the presence of microorganisms that have become resistant to antimicrobials and so it is important that different scientific tools are combined to achieve the largest amount of knowledge in this area of expertise. The emergence and spread of the antibiotic-resistant Gram-negative pathogens, such as Escherichia coli, can lead to serious problem public health in humans. E. coli, a very well described prokaryote, has served as a model organism for several biological and biotechnological studies increasingly so since the completion of the E. coli genome-sequencing project. The purpose of this review is to present an overview of the different proteomic approaches to antimicrobial-resistant E. coli that will be helpful to obtain a better knowledge of the antibiotic-resistant mechanism(s). This can also aid to understand the molecular determinants involved with pathogenesis, which is essential for the development of effective strategies to combat infection and to reveal new therapeutic targets. This article is part of a Special Issue entitled: Proteomics: The clinical link.
    Journal of proteomics 01/2012; 75(10):2773-89. DOI:10.1016/j.jprot.2011.12.035 · 3.93 Impact Factor


1 Download